Announcement on Implementation Result of Shares Repurchase and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation Result of Shares Repurchase and Share Changes
Filed with SSE · · 3 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-implementation-result-of-shares-repurchase-and-share-changes-25
Release
Zhejiang Medicine Co., Ltd. on 6ix
Earlier from Zhejiang Medicine
- Announcement on Progress in Repurchasing Shares
- Announcement on Expected Increase in Semi-annual Performance for 2025
- Announcement on Shares Repurchased Reaching 1% of the Company's Share Capital and Repurchase Progress
- Announcement on Election Results of Employee Directors for the 10th Board of Directors
- Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States
Later from Zhejiang Medicine
- Announcement on XC2309 Injection Obtaining Notice of Approval for Drug Clinical Trial
- 2025 Semi-annual Report
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Abstract of 2025 Restricted Stock Incentive Plan (Draft)
- Publicity Description and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Objects in the 2025 Restricted Stock Incentive Plan
Follow Zhejiang Medicine into a list and get an email when it puts out news.
Follow Zhejiang Medicine